Irhythm Technologies Inc (OQ:IRTC)
Business Focus: Medical Monitoring Systems
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 699 8th Street, Suite 600 SAN FRANCISCO CA 94103 |
| Tel: | N/A |
| Website: | https://www.irhythmtech.com |
| IR: | See website |
| Key People | ||
| Quentin S. Blackford President, Chief Executive Officer, Director | Brice Bobzien Chief Financial Officer | Reyna M. Fernandez Chief Human Resource Officer, Executive Vice President |
| Minang Turakhia Executive Vice President, Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer | Sumi Shrishrimal Executive Vice President, Chief Risk Officer | Daniel G. Wilson Executive Vice President - Corporate Development, Investor Relations |
| Mark J. Day Chief Technology Officer | Patrick M. Murphy Chief Business Officer, Chief Legal Officer | Chad M. Patterson Chief Commercial Officer |
| Business Overview |
| iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Irhythm Technologies Inc revenues increased 20% to $492.7M. Net loss increased 6% to $123.4M. Revenues reflect Contracted third-party payors segment increase of 19% to $267.2M, Centers for Medicare & Medicaid segment increase of 19% to $122.4M. Higher net loss reflects Selling, general and administrative - B increase of 12% to $307.6M (expense). |
| Employees: | 2,000 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $3,304M as of Dec 31, 2023 |
| Annual revenue (TTM): | $492.68M as of Dec 31, 2023 |
| EBITDA (TTM): | -$81.87M as of Dec 31, 2023 |
| Net annual income (TTM): | -$123.41M as of Dec 31, 2023 |
| Free cash flow (TTM): | -$90.53M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 31,121,015 as of Apr 3, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.